Skip to main content

Table 3 Participants with symptoms on at least one day of the intervention period

From: Effects of the regular intake of the probiotic Lactobacillus reuteri (DSM 17938) on respiratory and gastrointestinal infections in a workplace setting: a double-blind randomized placebo-controlled trial

 

Intervention group

Control group

p-valuea

 

(n = 79)

(n = 80)

 

Cough

50 (63.3%)

51 (63.8%)

0.95

Common cold

61 (77.2%)

57 (71.3%)

0.39

Hoarseness

35 (44.3%)

32 (40.0%)

0.58

Sore throat

38 (48.1%)

48 (60.0%)

0.13

Earache

12 (15.2%)

11 (13.8%)

0.80

Headache

47 (59.5%)

53 (66.3%)

0.38

Fever

18 (22.8%)

21 (26.3%)

0.61

Stomachache

19 (24.1%)

22 (27.5%)

0.62

Diarrhea

16 (20.3%)

30 (37.5%)

0.02

Vomiting

8 (10.1%)

2 (2.5%)

0.06b

Any symptom

67 (84.8%)

70 (87.5%)

0.62

  1. ap-values calculated using chi-square test or t-test.
  2. bp-value calculated using Fisher’s exact test.
Back to article page

BMC Nutrition

ISSN: 2055-0928

Contact us